Biotech Archives - Page 103 of 795

2 minute read

Athira Pharma Announces Publication In Frontiers In Neuroscience Highlighting Therapeutic Potential Of ATH-1105 In Amyotrophic Lateral Sclerosis

February 8, 5:22 PM

Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced publication of research

ATHA

2 minute read

Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?

By Vandana Singh

February 8, 3:59 PM

Adverum Biotechnologies' Ixo-vec gene therapy for wet AMD. Preliminary LUNA Phase 2 trial data show safety, efficacy, and significant treatment burden reduction.

ADVM

2 minute read

What’s Going On Eli Lilly Stock Thursday?

By Vandana Singh

February 8, 11:36 AM

Eli Lilly's impressive stock surge, better-than-expected Q4 results, and positive analyst reviews.

LLY

2 minute read

GE HealthCare and MedQuest Associates Collaborate To Provide Innovative Medical Device Technology And Digital Tools For Outpatient Imaging Centers

By Benzinga Newsdesk

February 8, 11:03 AM

GE HealthCare (NASDAQ:GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MedQuest Associates (MedQuest), a leading owner, operator, and manager of outpatient

GEHC

3 minute read

The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry

By Piero Cingari

February 8, 10:58 AM

Novo Nordisk's groundbreaking weight-loss treatments are causing concern in the food industry. CEOs are seeking advice from the company.

CMG

1 minute read

Biodexa Reports 12 Month Survival In MAGIC-G1 Study Of MTX110 In Recurrent Glioblastoma Patients

By Benzinga Newsdesk

February 8, 9:57 AM

Biodexa Pharmaceuticals PLCBiodexa Reports 12 Month Survival in MAGIC-G1 Studyof MTX110 in Recurrent Glioblastoma PatientsCARDIFF, United Kingdom, February 8, 2024 (GLOBE NEWSWIRE) -- Biodexa Pharmaceuticals PLC

BDRX

3 minute read

AbbVie’s VYALEV Available For The Treatment Of Advanced Parkinson’s Disease In Canada

By Benzinga Newsdesk

February 8, 9:16 AM

VYALEV is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson's disease (aPD) in Canada.Advanced Parkinson's disease patients now have a non-surgical

ABBV

5 minute read

Madrigal Pharmaceuticals Announces Publication Of The Phase 3 MAESTRO-NASH Trial Of Resmetirom In The New England Journal Of Medicine

By Benzinga Newsdesk

February 8, 9:02 AM

Resmetirom is the first investigational medicine for NASH to achieve fibrosis improvement and NASH resolution primary endpoints in a Phase 3 trialDetailed analyses reinforce the safety profile of resmetiromResmetirom has

MDGL

1 minute read

The UK National Institute For Health And Care Excellence Issues Final Draft Guidance To Provide Patients With A Natural Lens Being Treated For Chronic Diabetic Macular Edema Access To ILUVIEN

By Benzinga Newsdesk

February 8, 9:01 AM

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer,

ALIM

2 minute read

AstraZeneca Stock Tumbles After Q4 Performance – Here’s Why

By Vandana Singh

February 8, 8:51 AM

AstraZeneca Q4 2023: $12.02 billion sales, 7% Y/Y growth, fueled by global demand for cancer drugs. Excluding COVID-19 meds, revenue rises 16%. CEO Soriot projects low double-digit growth in 2024.

AZN